Cargando…

Area Deprivation Index and Oral Anticoagulation in New Onset Atrial Fibrillation

OBJECTIVE: Oral anticoagulation is a standard of care for thromboembolic stroke prevention in individuals with atrial fibrillation (AF). Social determinants of health have had limited investigation in AF and particularly in access to anticoagulation. We examined the relation between area deprivation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Omole, Toluwa D., Zhu, Jianuhi, Garrard, William, Thoma, Floyd W., Mulukutla, Suresh, McDermott, Annie, Herbert, Brandon M., Essien, Utibe R., Magnani, Jared W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Research Contribution
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066349/ https://www.ncbi.nlm.nih.gov/pubmed/35517873 http://dx.doi.org/10.1016/j.ajpc.2022.100346

Ejemplares similares

Area Deprivation Index and Cardiac Readmissions: Evaluating Risk‐Prediction in an Electronic Health Record
por: Johnson, Amber E., et al.
Publicado: (2021)

Sex differences in atrial fibrillation: patient-reported outcomes and the persistent toll on women
por: Silva, Raisa L., et al.
Publicado: (2021)

Association of income and educational attainment in hospitalization events in atrial fibrillation
por: Tertulien, Tarryn, et al.
Publicado: (2021)

Disparities in Anticoagulant Therapy Initiation for Incident Atrial Fibrillation by Race/Ethnicity Among Patients in the Veterans Health Administration System
por: Essien, Utibe R., et al.
Publicado: (2021)

Separate and Unequal: The Cost of Coronavirus Disease 2019 on Childhood Health and Well-Being
por: Magnani, Jared W., et al.
Publicado: (2021)

Association of Fine Particulate Matter and Risk of Stroke in Patients With Atrial Fibrillation
por: Rhinehart, Zachary J., et al.
Publicado: (2020)

Association of Race and Ethnicity on the Management of Acute Non−ST‐Segment Elevation Myocardial Infarction
por: Tertulien, Tarryn, et al.
Publicado: (2022)

Racial and Urban-Rural Difference in the Frequency of Ischemic Stroke as Initial Manifestation of Atrial Fibrillation
por: Guo, Jingchuan, et al.
Publicado: (2021)

Heterogeneity in past-year smoking, current tobacco use, and smoking cessation behaviors among light and/or non-daily smokers
por: Omole, Toluwa, et al.
Publicado: (2020)

Analysis of Initiating Anticoagulant Therapy for Atrial Fibrillation Among Persons Experiencing Homelessness in the Veterans Affairs Health System
por: Wilson, David A., et al.
Publicado: (2022)

Comparative Safety and Effectiveness of Oral Anticoagulants in Nonvalvular Atrial Fibrillation: The NAXOS Study
por: Van Ganse, Eric, et al.
Publicado: (2020)

Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients: The ARISTOPHANES Study
por: Lip, Gregory Y.H., et al.
Publicado: (2018)

COVID-19 pandemic and trends in new diagnosis of atrial fibrillation: A nationwide analysis of claims data
por: Hernandez, Inmaculada, et al.
Publicado: (2023)

Association of Oral Anticoagulation With Stroke in Atrial Fibrillation or Heart Failure: A Comparative Meta-Analysis
por: Reddin, Catriona, et al.
Publicado: (2021)

County-level variation in cardioprotective antihyperglycemic prescribing among medicare beneficiaries
por: Hanna, Jonathan, et al.
Publicado: (2022)

Non–Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients With Intracerebral Hemorrhage
por: Nielsen, Peter Brønnum, et al.
Publicado: (2019)

Time Trends in Atrial Fibrillation-Associated Stroke and Premorbid Anticoagulation: Population-Based Study and Systematic Review
por: Yiin, Gabriel S.C., et al.
Publicado: (2019)

Non–Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Asian Patients With Nonvalvular Atrial Fibrillation: Meta-Analysis
por: Wang, Kang-Ling, et al.
Publicado: (2015)

COVID‐19 and Anticoagulation for Atrial Fibrillation: An Analysis of US Nationwide Pharmacy Claims Data
por: Hernandez, Inmaculada, et al.
Publicado: (2021)

Impact of cigarette taxes on smoking prevalence from 2001-2015: A report using the Behavioral and Risk Factor Surveillance Survey (BRFSS)
por: Sharbaugh, Michael S., et al.
Publicado: (2018)

Non–Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Asians With Atrial Fibrillation: Meta-Analysis of Randomized Trials and Real-World Studies
por: Xue, Zhengbiao, et al.
Publicado: (2019)

Inverse association of mortality and body mass index in patients with left ventricular systolic dysfunction of both ischemic and non‐ischemic etiologies
por: Brazile, Tiffany, et al.
Publicado: (2021)

Trends in Anticoagulation Prescription Spending Among Medicare Part D and Medicaid Beneficiaries Between 2014 and 2019
por: Duvalyan, Angela, et al.
Publicado: (2021)

Cost-Effectiveness of Left Atrial Appendage Closure With the WATCHMAN Device Compared With Warfarin or Non–Vitamin K Antagonist Oral Anticoagulants for Secondary Prevention in Nonvalvular Atrial Fibrillation
por: Reddy, Vivek Y., et al.
Publicado: (2018)

Practical “1-2-3-4-Day” Rule for Starting Direct Oral Anticoagulants After Ischemic Stroke With Atrial Fibrillation: Combined Hospital-Based Cohort Study
por: Kimura, Shunsuke, et al.
Publicado: (2022)

Inpatient hemodialysis without anticoagulation in adults
por: Sahota, Sheena, et al.
Publicado: (2014)

Lifetime healthcare expenses across demographic and cardiovascular risk groups: The application of a novel modeling strategy in a large multiethnic cohort study
por: Khera, Rohan, et al.
Publicado: (2023)

The impact of mental health conditions on oral anticoagulation therapy and outcomes in patients with atrial fibrillation: A systematic review and meta-analysis
por: Teppo, Konsta, et al.
Publicado: (2021)

Association of Prescription Co-payment With Adherence to Glucagon-Like Peptide-1 Receptor Agonist and Sodium-Glucose Cotransporter-2 Inhibitor Therapies in Patients With Heart Failure and Diabetes
por: Essien, Utibe R., et al.
Publicado: (2023)

Cardiovascular Hospitalizations and Resource Use Following Atrial Fibrillation Ablation
por: Dhande, Mehak, et al.
Publicado: (2023)

Anticoagulation in chronic kidney disease patients—the practical aspects
por: Hughes, Stephen, et al.
Publicado: (2014)

Impact of a dedicated center for atrial fibrillation on resource utilization and costs
por: Medhekar, Ankit, et al.
Publicado: (2023)

Exendin-4 attenuates adverse cardiac remodelling in streptozocin-induced diabetes via specific actions on infiltrating macrophages
por: Tate, Mitchel, et al.
Publicado: (2015)

Effect of the COVID-19 pandemic on adversity in individuals receiving anticoagulation for atrial fibrillation: A nationally representative administrative health claims analysis
por: Hernandez, Inmaculada, et al.
Publicado: (2022)

Characteristics of trauma mortality in the Northern Territory, Australia
por: McDermott, Kathleen M., et al.
Publicado: (2017)

Adapting to a new normal: Antiracism as a core public health principle
por: Essien, Utibe R., et al.
Publicado: (2021)

Improving Mental Health Through the Regeneration of Deprived Neighborhoods: A Natural Experiment
por: White, James, et al.
Publicado: (2017)

Underprescribing vs underfilling to oral anticoagulation: An analysis of linked medical record and claims data for a nationwide sample of patients with atrial fibrillation
por: Guo, Jingchuan Serena, et al.
Publicado: (2022)

Sweet taste perception not altered after acute sleep deprivation in healthy young men
por: Hogenkamp, P.S., et al.
Publicado: (2013)

The association of material deprivation component measures with injury hospital separations in British Columbia, Canada
por: Rajabali, Fahra, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vm6gqahaq44k0bpe6jtbo6ltgn